Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: Effects on interleukin-6 to interleukin-10 ratio and early outcome

Critical Care Medicine

Volumn 37, Issue 5, 2009, Pages 1685-1690

  Weis, Florian ^a   Beiras Fernandez, Andres ^a   Schelling, Gustav ^a   Briegel, Josef ^a   Lang, Philip ^a   Hauer, Daniela ^a   Kreth, Simone ^a   Kaufmann, Ines ^a   Lamm, Peter ^a   Kilger, Erich ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cardiac surgery; Hydrocortisone; Stress; Systemic inflammatory response syndrome

Indexed keywords

CATECHOLAMINE; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HIGH RISK PATIENT; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTENSIVE CARE UNIT; LOADING DRUG DOSE; MALE; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGED; BIOLOGICAL MARKERS; CARDIAC CARE FACILITIES; CARDIAC SURGICAL PROCEDURES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROCORTISONE; INJECTIONS, INTRAVENOUS; INTENSIVE CARE UNITS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 67650489578     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819fca77     Document Type: Article

References (31)

1. Marshall JC: SIRS and MODS: What is their relevance to the science and practice of intensive care? Shock 2000; 14:586-589
2. Annane D, Bellissant E, Bollaert PE, et al: Corticosteroids for severe sepsis and septic shock: A systematic review and metaanalysis. BMJ 2004; 329:480
3. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
4. Sprung CL, Annane D, Keh D, et al: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
5. Marik PE, Pastores SM, Annane D, et al: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36:1937-1949
6. Rohleder N, Wolf JM, Kirschbaum C: Glucocorticoid sensitivity in humans-interindi- vidual differences and acute stress effects. Stress 2003; 6:207-222
7. Deans KJ, Minneci PC, Suffredini AF, et al: Randomization in clinical trials of titrated therapies: Unintended consequences of using fixed treatment protocols. Crit Care Med 2007; 35:1509-1516
8. Taniguchi T, Koido Y, Aiboshi J, et al: Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999; 27: 1262-1264
9. Taniguchi T, Koido Y, Aiboshi J, et al: The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am J Emerg Med 1999; 17:548-551
10. Rubens FD, Mesana T: The inflammatory response to cardiopulmonary bypass: A therapeutic overview. Perfusion 2004; 19(Suppl 1): S5-S12
11. Chaney MA: Corticosteroids and cardiopul-monary bypass: A review of clinical investigations. Chest 2002; 121:921-931
12. Kilger E, Weis F, Briegel J, et al: Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003; 31:1068-1074
13. Weis F, Kilger E, Roozendaal B, et al: Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: A randomized study. J Thorac Cardiovasc Surg 2006; 131:277-282
14. Halonen J, Halonen P, Jarvinen O, et al: Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A randomized controlled trial. JAMA 2007; 297: 1562-1567
15. Briegel J, Kellermann W, Forst H, et al: Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The Phospholipase A2 Study Group. Clin Investig 1994; 72:782-787
16. Briegel J: [Introduction to the topic: How much hydrocortisone does the patient really need? The (anti-)stress hormone in the perioperative phase]. Anaesthesist 2005; 54: 637-638
17. Knaus WA, Draper EA, Wagner DP, et al: Acute Physiology and Chronic Health Evaluation II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
18. Damas P, Ledoux D, Nys M, et al: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215:356-362
19. Weis F, Kilger E, Beiras-Fernandez A, et al: Association between vasopressor dependence and early outcome in patients after cardiac surgery. Anaesthesia 2006; 61:938-942
20. Markewitz A, Lante W, Franke A, et al: Alterations of cell-mediated immunity following cardiac operations: Clinical implications and open questions. Shock 2001; 16(Suppl 1): 10-15
21. Duggan E, Caraher E, Gately K, et al: Tumor necrosis factor-alpha and interleukin-10 gene expression in peripheral blood mononuclear cells after cardiac surgery. Crit Care Med 2006; 34:2134-2139
22. Allen ML, Hoschtitzky JA, Peters MJ, et al: Interleukin-10 and its role in clinical immu-noparalysis following pediatric cardiac surgery. Crit Care Med 2006; 34:2658-2665
23. Tassani P, Richter JA, Barankay A, et al: Does high-dose methylprednisolone in aprotinintreated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures? J Cardiothorac Vasc Anesth 1999; 13:165-172
24. Kawamura T, Inada K, Nara N, et al: Influence of methylprednisolone on cytokine balance during cardiac surgery. Crit Care Med 1999; 27:545-548
25. Morariu AM, Loef BG, Aarts LP, et al: Dexamethasone: Benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: A study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005; 128:2677-2687
26. Munck A, Guyre PM, Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984; 5:25-44
27. Galon J, Franchimont D, Hiroi N, et al: Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002; 16:61-71
28. Liakopoulos OJ, Schmitto JD, Kazmaier S, et al: Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann Thorac Surg 2007; 84: 110-118
29. Chappell D, Jacob M, Hofmann-Kiefer K, et al: Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007; 107:776-784
30. Rehm M, Bruegger D, Christ F, et al: Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116:1896-1906
31. Deng MC, Dasch B, Erren M, et al: Impact of left ventricular dysfunction on cytokines, he-modynamics, and outcome in bypass grafting. Ann Thorac Surg 1996; 62:184-190